Millennium Group and Israel Englander report 5.7% stake in Protara (TARA)

Rhea-AI Filing Summary

Protara Therapeutics disclosure: reporting groups state shared beneficial ownership positions. Integrated Core Strategies (US) LLC reports 2,879,674 shares with shared voting and dispositive power, equal to 5.1%. Millennium Management LLC, Millennium Group Management LLC and Israel A. Englander each report 3,201,936 shares with shared voting and dispositive power, equal to 5.7%. The filing is an Amendment No. 1 to a Schedule 13G/A and includes a Joint Filing Agreement dated July 6, 2026. Signatures are provided by Gil Raviv and Israel A. Englander.

Insights

Institutional Holdings Analyst

Large institutional owners report passive shared positions near single‑digit stakes.

The filing lists specific share counts: 2,879,674 shares (5.1%) attributed to Integrated Core Strategies (US) LLC and 3,201,936 shares (5.7%) attributed to Millennium entities and Mr. Englander. These counts are reported as shared voting and dispositive power.

Disclosure clarifies the holdings are held by entities subject to voting control and investment discretion by Millennium Management LLC and related managers. Subsequent filings may further specify aggregation or voting arrangements.

Corporate Governance Counsel

Filing formalizes joint reporting and attributes shared control across related entities.

The Schedule 13G/A amendment incorporates a Joint Filing Agreement dated July 6, 2026 and repeats the parties' addresses and citizenships. It states shared voting/dispositive power rather than sole control, and includes signature blocks for the reporting parties.

Relevant qualifiers (shared power, entity relationships) are preserved verbatim in the filing; any legal attribution of beneficial ownership is expressly limited by the filers' statement.

Key Figures

Integrated Core shared shares: 2,879,674 shares Integrated Core percent: 5.1% Millennium shared shares: 3,201,936 shares +2 more

5 metrics

Integrated Core shared shares 2,879,674 shares shared voting and dispositive power, Item 6/8

Integrated Core percent 5.1% percent of class reported on cover page

Millennium shared shares 3,201,936 shares shared voting and dispositive power, Item 6/8

Millennium percent 5.7% percent of class reported on cover page

Joint Filing Agreement date July 6, 2026 Exhibit I to the amendment

Key Terms

Shared Dispositive Power, Schedule 13G/A, Joint Filing Agreement

3 terms

Shared Dispositive Power regulatory

"Shared Dispositive Power 2,879,674.00 3,201,936.00"

Schedule 13G/A regulatory

"Amendment No. 1 to a Schedule 13G/A"

A Schedule 13G/A is an amended public filing with the U.S. securities regulator that updates a previous Schedule 13G, disclosing when an individual or group holds a substantial (typically over 5%) stake in a company and is claiming a passive, non‑controlling intent. Investors monitor these updates because rising or falling holdings can signal changing confidence, potential future moves, or shifts in voting power — like watching a public ledger where large shareholders quietly adjust their positions.

Joint Filing Agreement legal

"Joint Filing Agreement, dated as of July 6, 2026"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 07/07/2026 - 06:43 PM Accepted by SEC EDGAR 07/07/2026 - 06:42 PM Learn about SEC filing dates

FAQ

What stake does Millennium Management report in Protara (TARA)?

Millennium Management LLC reports shared voting and dispositive power over 3,201,936 shares, representing 5.7% of the class. This figure appears on the cover page and is dated in the amendment filing signed July 6, 2026.

How many shares does Integrated Core Strategies report for TARA?

Integrated Core Strategies (US) LLC reports shared voting and dispositive power over 2,879,674 shares, representing 5.1% of the class. The amount is disclosed on the filing cover page and in Item 4 references.

Who signed the Schedule 13G/A amendment for TARA?

The amendment is signed by Gil Raviv, Global General Counsel, on behalf of the reporting entities, and by Israel A. Englander. The signatures are dated 07/06/2026 on the filing's signature lines.

Does the filing state sole voting control for these holdings in TARA?

No. The filing explicitly reports shared voting and dispositive power for the listed share amounts. It states 0 for sole voting power and sole dispositive power and provides shared power counts instead.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 1)

Protara Therapeutics, Inc.

(Name of Issuer)

Common Stock, par value $0.001 per share

(Title of Class of Securities)

74365U107

(CUSIP Number)

07/01/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP Number(s): 74365U107

1

Names of Reporting Persons

Integrated Core Strategies (US) LLC

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 2,879,674.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 2,879,674.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

2,879,674.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

5.1 %

12

Type of Reporting Person (See Instructions)

OO

SCHEDULE 13G

CUSIP Number(s): 74365U107

1

Names of Reporting Persons

Millennium Management LLC

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 3,201,936.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 3,201,936.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

3,201,936.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

5.7 %

12

Type of Reporting Person (See Instructions)

OO

SCHEDULE 13G

CUSIP Number(s): 74365U107

1

Names of Reporting Persons

Millennium Group Management LLC

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 3,201,936.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 3,201,936.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

3,201,936.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

5.7 %

12

Type of Reporting Person (See Instructions)

OO

SCHEDULE 13G

CUSIP Number(s): 74365U107

1

Names of Reporting Persons

Israel A. Englander

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 3,201,936.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 3,201,936.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

3,201,936.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

5.7 %

12

Type of Reporting Person (See Instructions)

IN

SCHEDULE 13G

Item 1.
(a)	Name of issuer: Protara Therapeutics, Inc.
(b)	Address of issuer's principal executive offices: 345 Park Avenue South, 3rd Floor, New York, New York 10010
Item 2.
(a)	Name of person filing: Integrated Core Strategies (US) LLC Millennium Management LLC Millennium Group Management LLC Israel A. Englander
(b)	Address or principal business office or, if none, residence: Integrated Core Strategies (US) LLC c/o Millennium Management LLC 399 Park Avenue New York, New York 10022 Millennium Management LLC 399 Park Avenue New York, New York 10022 Millennium Group Management LLC 399 Park Avenue New York, New York 10022 Israel A. Englander c/o Millennium Management LLC 399 Park Avenue New York, New York 10022
(c)	Citizenship: Integrated Core Strategies (US) LLC - Delaware Millennium Management LLC - Delaware Millennium Group Management LLC - Delaware Israel A. Englander - United States
(d)	Title of class of securities: Common Stock, par value $0.001 per share
(e)	CUSIP No.: 74365U107
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: See response to Item 9 on each cover page.
(b)	Percent of class: See response to Item 11 on each cover page.
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: See response to Item 5 on each cover page.
	(ii) Shared power to vote or to direct the vote: See response to Item 6 on each cover page.
	(iii) Sole power to dispose or to direct the disposition of: See response to Item 7 on each cover page.
	(iv) Shared power to dispose or to direct the disposition of: See response to Item 8 on each cover page. The securities disclosed herein as potentially beneficially owned by Millennium Management LLC, Millennium Group Management LLC and Mr. Englander are held by entities subject to voting control and investment discretion by Millennium Management LLC and/or other investment managers that may be controlled by Millennium Group Management LLC (the managing member of Millennium Management LLC) and Mr. Englander (the sole voting trustee of the managing member of Millennium Group Management LLC). The foregoing should not be construed in and of itself as an admission by Millennium Management LLC, Millennium Group Management LLC or Mr. Englander as to beneficial ownership of the securities held by such entities.
Item 5.	Ownership of 5 Percent or Less of a Class.
	Not Applicable
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Integrated Core Strategies (US) LLC

Signature:	/s/ Gil Raviv
Name/Title:	Gil Raviv, Global General Counsel
Date:	07/06/2026

Millennium Management LLC

Signature:	/s/ Gil Raviv
Name/Title:	Gil Raviv, Global General Counsel
Date:	07/06/2026

Millennium Group Management LLC

Signature:	/s/ Gil Raviv
Name/Title:	Gil Raviv, Global General Counsel
Date:	07/06/2026

Israel A. Englander

Signature:	/s/ Israel A. Englander
Name/Title:	Israel A. Englander
Date:	07/06/2026

Comments accompanying signature: ** INTEGRATED CORE STRATEGIES (US) LLC By: Integrated Holding Group LP, its Managing Member By: Millennium Management LLC, its General Partner

Exhibit Information

Exhibit I: Joint Filing Agreement, dated as of July 6, 2026, by and among Integrated Core Strategies (US) LLC, Millennium Management LLC, Millennium Group Management LLC and Israel A. Englander.